Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Endpoints News
endpoints.news > akeso-details-survival-win-for-its-pd-1xvegf-drug-versus-keytruda

Akeso details survival win for its PD-1xVEGF drug versus Keytruda

4+ hour, 49+ min ago   (76+ words) Endpoints News Ake­so de­tails sur­vival win for its PD-1xVEGF drug ver­sus Keytru­da Ake­so and Sum­mit Ther­a­peu­tics claimed a key win over Keytru­da at the start of Sep­tem­ber,…...

firstwordpharma.com
firstwordpharma.com > story > 7983565

AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial

43+ min ago   (12+ words) firstwordpharma.com...

BIOENGINEER.ORG
bioengineer.org > scientists-flip-the-drug-discovery-pipeline-to-put-human-biology-first-in-cardiovascular-research

Scientists Flip the Drug Discovery Pipeline to Put Human Biology First in

just now   (704+ words) Cardiovascular medicine is quietly undergoing a structural rethink, and the change begins with the order of operations....

BIOENGINEER.ORG
bioengineer.org > ai-that-learns-the-rules-symbolic-neural-generators-design-new-drug-candidates

AI That Learns the Rules: Symbolic Neural Generators Design New Drug

33+ min ago   (90+ words) Artificial intelligence has become an increasingly powerful tool in the search for new medicines, but a persistent problem has haunted the field: neural networks that invent molecules are remarkably creative yet notoriously unreliable. They can propose chemical structures that look…...

BIOENGINEER.ORG
bioengineer.org > what-matters-most-patients-define-health-values-in-cardiovascular-kidney-metabolic-syndrome

What Matters Most: Patients Define Health Values in

1+ hour, 34+ min ago   (721+ words) A new qualitative study from China offers one of the most detailed maps to date of what patients with cardiovascular-kidney-metabolic syndrome actually value about their health, and the picture that emerges is strikingly broader than the clinical targets that dominate…...

The Washington Post
washingtonpost.com > health > 06/09/2025 > illegal-psychedelic-ibogaine-texas

Why Texas is spending millions to research an illegal psychedelic

4+ week, 2+ day ago   (100+ words) Breaking news and analysis on politics, business, world, national news, entertainment and more. In-depth DC, Virginia, Maryland news coverage including traffic, weather, crime, education, restaurant reviews and more. Ibogaine is illegal in the United States, but Texas is on the…...

redstate.com
redstate.com > wardclark > 09/12/2026 > new-biohacker-company-promises-unicorns-whats-the-catch-n2206845

New Biohacker Company Promises Unicorns. What’s the Catch?

10+ hour, 40+ min ago   (432+ words) Unicorns, dragons, pixies, and the like are the stuff of kids' stories, or at least they should be. But now a new Texas startup, a bioengineering firm, The Embryo Corporation, is looking at the possibility of producing these creatures for…...

BIOENGINEER.ORG
bioengineer.org > triple-drug-antibody-drug-conjugate-strategy-shows-promise-in-hard-to-treat-breast-cancer

Triple-Drug Antibody-Drug Conjugate Strategy Shows Promise in Hard-to-Treat

7+ hour, 39+ min ago   (55+ words) Metastatic triple-negative breast cancer remains one of the most formidable challenges in oncology. Lacking the estrogen receptor, progesterone receptor, and HER2 that anchor targeted therapies in other breast cancer subtypes, this aggressive disease leaves patients with few options once first-line treatment…...

Medium
medium.com > @macrointegration > this-week-in-psychedelic-news-bfc9497ccc00

This Week in Psychedelic News…

10+ hour, 28+ min ago   (500+ words) Does THC have the same psychedelic trip potential as psilocybin? And can psilocybin relieve a debilitating chemotherapy side effect? A curated roundup of good reads …...

Yahoo Finance
finance.yahoo.com > healthcare > articles > novartis-investors-turn-spotlight-m-050159138.html

Novartis investors turn spotlight on M&A after trial setbacks

1+ day, 13+ hour ago   (418+ words) By Bhanvi Satija, Oliver Hirt and Marleen Kaesebier LONDON/ZURICH, Sept 11 (Reuters) - Novartis investors are set to step up scrutiny of the Swiss group's dealmaking strategy after setbacks to drugs...